ArthNow Logo
ArthNow
•5 min read•
✦Reported by Business Standard

Sonu Nigam buys offices for ₹17 cr, leases them back for Rs 12 lakh/month

Sonu Nigam buys offices for ₹17 cr, leases them back for Rs 12 lakh/month
Source: Business Standard

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓Playback singer Sonu Nigam bought three commercial units in Mumbai for ₹17 crore and leased them back for ₹12 lakh monthly.
  • ✓The five-year agreement with Singular Health Private Limited was registered on November 3.
  • ✓This sale-and-leaseback deal covers 4,144 sq ft in the Aston building at the Sundervan Complex area.

Story at a Glance

Category
Indian Markets
Reported By
Business Standard
Reading Speed
5 Minute(s)
Market Focus
India Economy

Playback singer Sonu Nigam has leased out three commercial units in Mumbai's Andheri West to Singular Health Private Limited for a combined monthly rent of ₹12 lakh, months after purchasing the same properties from the company for ₹17 crore, according to property documents accessed by CRE Matrix.

The five-year leave-and-licence agreement was registered on November 3, 2026. The properties are located in the Aston building at Sundervan Complex on Lokhandwala Road and have a combined carpet area of approximately 4,144 sq ft.

The arrangement is structured as a sale-and-leaseback transaction. Singular Health, which previously owned the units, sold them to Nigam in August and has now taken the premises back on lease.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

Business Standard

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.